Latest Period
Q1 2026
Security Snapshot
Minerva Neurosciences, Inc. - Common Stock, par value $0.0001 per share (NERV) Institutional Ownership
CUSIP: 603380205
13F Institutional Holders and Ownership History from Q2 2022 to Q1 2026
Institutions Reporting
43
Shares (Excl. Options)
38,297,681
Price
$6.02
Save this security page for your next review
Keep this CUSIP in your watchlists so you can revisit quarter changes from one place. If you create an account from here, we will bring you back after verification.
- Security type / class
- Equity / Common Stock, par value $0.0001 per share
- Symbol
- NERV on Nasdaq
- All holders as of 31 Mar 2026
- Q1 2026
- Total 13F shares
- 38,297,681
- Total reported value
- $230,775,656
- Portfolio coverage rank
- 0%
- Share change
- +9,060,551
- Value change
- +$54,667,446
- Number of holders
- 43
- Shares outstanding
- 45,675,986
- Reported price per share
- $6.13
Latest holder snapshot
5 facts
Issuer context
2 facts
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Total Investors
Key facts
- NERV - Minerva Neurosciences, Inc. - Common Stock, par value $0.0001 per share is tracked under CUSIP 603380205.
- 43 institutions reported positions in Q1 2026.
- 7 significant owners is listed from Schedule 13D/13G reporting.
Change
- Holder count moved from 29 to 43 between Q4 2025 and Q1 2026.
- Reported value moved from $90,576,655 to $230,775,656.
Research use
- You can quickly see who holds this security, then open quarter and manager detail pages for full evidence.
- 13F and Schedule 13D/13G sections are kept together so you can cross-check institutional and beneficial ownership context.
Evidence
Source: SEC Form 13F
Open SEC Evidence
Latest holder context comes from 43 institutions filings for Q1 2026.
Security key
603380205
Latest holder period
Q1 2026
13F holders
43
13D/G owners
7
CIK / CUSIP context first
Open Q1 2026 holders
NERV full holder history
Minerva Neurosciences, Inc. SEC filings
Minerva Neurosciences, Inc. company facts
Minerva Neurosciences, Inc. insider transactions
Broader feeds
Recent Quarterly Holder Reports
Open recent reporting periods for CUSIP 603380205:
13D/G owners
Significant owners
Large-stake holder rows connected to Schedule 13D/G evidence.
Rows
7
Security
NERV
| Filer | Ownership | Change % | Holdings Value | Net Change | Nb Shares | Change % | Reporting Name | Report Period |
|---|---|---|---|---|---|---|---|---|
| FEDERATED HERMES, INC. | 20% | +2.8% | $35,502,800 | +$30,394,980 | 9,392,275 | +595% | Federated Hermes, Inc. | 22 Dec 2025 |
| Vivo Opportunity Fund Holdings, L.P. | 10% | $32,476,142 | 8,591,572 | Vivo Opportunity Fund Holdings, L.P. | 23 Dec 2025 | |||
| Coastlands Capital LP | 10% | $18,571,536 | 4,563,031 | Coastlands Capital LP | 13 Feb 2026 | |||
| Farallon Capital Partners, L.P. | 10% | 0% | $18,250,213 | 4,539,854 | 0% | Dapice Joshua J. | 31 Dec 2025 | |
| Logos Global Management LP | 9.9% | $18,407,093 | 4,435,444 | Logos Global Management LP | 23 Dec 2025 | |||
| BALYASNY ASSET MANAGEMENT L.P. | 10% | $17,970,807 | 4,330,315 | Balyasny Asset Management L.P. | 31 Dec 2025 | |||
| Adage Capital Management, L.P. | 6.4% | $11,777,700 | 2,838,000 | Adage Capital Management, L.P. | 31 Dec 2025 |
As of 31 Mar 2026, 43 institutional investors reported holding 38,297,681 shares of Minerva Neurosciences, Inc. - Common Stock, par value $0.0001 per share (NERV). This represents 84% of the company’s total 45,675,986 outstanding shares.
13F concentration
Top 25 institutional shareholders
Largest 13F positions for this security by reported shares and value.
Top holder share
83%
| Institution | Ownership % | Shares Held | Share Change % | Portfolio % | Holdings Value |
|---|---|---|---|---|---|
| FEDERATED HERMES, INC. | 11% | 5,113,224 | -4.8% | 0.05% | $30,807,175 |
| Vivo Capital, LLC | 9.5% | 4,322,747 | 0% | 2.2% | $26,044,551 |
| JANUS HENDERSON GROUP PLC | 9.4% | 4,294,259 | 0% | 0.01% | $25,872,910 |
| Balyasny Asset Management L.P. | 9.3% | 4,258,600 | 0.05% | $25,658,065 | |
| Logos Global Management LP | 7% | 3,215,000 | -2.9% | 1% | $19,370,375 |
| FARALLON CAPITAL MANAGEMENT LLC | 5.2% | 2,365,000 | 0% | 0.09% | $14,249,125 |
| Foresite Capital Management VI LLC | 4.3% | 1,986,600 | 2.6% | $11,969,265 | |
| VANGUARD CAPITAL MANAGEMENT LLC | 4% | 1,845,831 | 0% | 0% | $11,121,132 |
| Ally Bridge Group (NY) LLC | 3.6% | 1,655,500 | 0% | 9.9% | $9,974,388 |
| Spruce Street Capital LP | 3.6% | 1,655,500 | 0% | 2.4% | $9,974,388 |
| Trails Edge Capital Partners, LP | 3.1% | 1,419,000 | 2% | $8,549,475 | |
| ADAGE CAPITAL PARTNERS GP, L.L.C. | 3.1% | 1,419,000 | -50% | 0.01% | $8,549,475 |
| DV Trading LLC | 1.9% | 889,254 | 0.49% | $5,357,755 | |
| ACUTA CAPITAL PARTNERS, LLC | 1.6% | 709,500 | 0% | 3% | $4,274,738 |
| MILLENNIUM MANAGEMENT LLC | 1.6% | 708,291 | +414% | 0% | $4,267,453 |
| BlackRock, Inc. | 1.4% | 624,857 | +760% | 0% | $3,764,763 |
| GEODE CAPITAL MANAGEMENT, LLC | 0.74% | 338,735 | +384% | 0% | $2,042,845 |
| VANGUARD FIDUCIARY TRUST CO | 0.58% | 264,047 | 0% | 0% | $1,590,883 |
| Seven Fleet Capital Management LP | 0.54% | 248,476 | 0.48% | $1,497,068 | |
| MARSHALL WACE, LLP | 0.48% | 218,759 | 0% | $1,319,117 | |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | 0.26% | 119,131 | 0% | $717,764 | |
| NORTHERN TRUST CORP | 0.2% | 93,308 | 0% | $562,181 | |
| RENAISSANCE TECHNOLOGIES LLC | 0.2% | 89,700 | -40% | 0% | $540,444 |
| UBS Group AG | 0.15% | 67,570 | +3639% | 0% | $407,109 |
| STATE STREET CORP | 0.12% | 56,349 | +135% | 0% | $339,503 |
Quarter history
Institutional holders across reporting periods
Holder count, reported shares/value, and median price by quarter.
Periods
16
Latest
Q1 2026
Rows shown
1-16 of 16
| Period | Reported Shares, Excl. Options | Value, Excl. Options | Value Change | Price (Median) | Investors |
|---|---|---|---|---|---|
| 2026 Q1 | 38,297,681 | $230,775,656 | +$54,667,446 | $6.02 | 43 |
| 2025 Q4 | 23,063,409 | $90,576,655 | +$76,545,252 | $4.02 | 29 |
| 2025 Q3 | 1,979,675 | $4,208,645 | +$81,860 | $2.10 | 22 |
| 2025 Q2 | 1,944,466 | $3,341,879 | -$12,369 | $1.72 | 18 |
| 2025 Q1 | 1,951,817 | $3,310,087 | -$310,831 | $1.70 | 19 |
| 2024 Q4 | 2,085,897 | $4,630,050 | -$81,975 | $2.22 | 21 |
| 2024 Q3 | 2,118,026 | $5,654,665 | +$83,536 | $2.67 | 19 |
| 2024 Q2 | 2,086,302 | $6,654,936 | -$42,908 | $3.19 | 20 |
| 2024 Q1 | 2,099,790 | $5,416,495 | -$2,569,915 | $2.58 | 20 |
| 2023 Q4 | 2,415,482 | $14,854,825 | +$68,371 | $6.15 | 19 |
| 2023 Q3 | 2,403,051 | $16,580,809 | +$303,012 | $6.90 | 19 |
| 2023 Q2 | 2,352,300 | $19,044,605 | +$5,865,507 | $9.14 | 18 |
| 2023 Q1 | 1,680,901 | $2,687,500 | -$78,110 | $1.60 | 14 |
| 2022 Q4 | 1,729,786 | $2,748,707 | -$3,027,635 | $1.59 | 17 |
| 2022 Q3 | 2,028,914 | $18,733,000 | -$1,898,373 | $9.24 | 23 |
| 2022 Q2 | 2,269,165 | $7,508,000 | +$7,508,000 | $3.31 | 20 |